Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
ORCHPHARMA | NSE
36.85
7.64%
Healthcare
Drug Manufacturers-Specialty & Generic
31/03/2024
01/04/2026
519.30
494.00
526.40
488.50
Orchid Pharma Limited a pharmaceutical company engages in the development manufacture and marketing of active pharmaceutical ingredients bulk actives finished dosage formulations and nutraceuticals in India. Its active pharmaceutical ingredients product portfolio includes oral cephalosporins injectable cephalosporins veterinary products and non-antibiotics. The company's multi-therapeutic presence in anti-infectives anti-inflammatory central nervous system cardiovascular segment nutraceuticals and other oral and sterile products as well as offers new drug discovery systems and pharmaceutical research and development services. It also exports its products to approximately 40 countries internationally. In addition the company provides liaising support to customers in regulatory pharma covigilance testing and release retention of samples service providers and business development. The company was formerly known as Orchid Chemicals & Pharmaceuticals Limited and changed its name to Orchid Pharma Limited in October 2015. Orchid Pharma Limited was incorporated in 1992 and is headquartered in Chennai India. As of March 31 2020 Orchid Pharma Limited operates as a subsidiary of Dhanuka Laboratories Limited.
View LessLow Debt to Equity (< 0.25)
Low Debt to Asset (< 0.2)
Strong Revenue Growth (> 10%)
High Short-term Volatility
Microcap (<300M USD)
High Market Beta (> 0.8)
Weak Operating Margin (< 10%)
Weak Sharpe Ratio (< 0.3)
Bullish: Stable Volatility (6-month <= 1-month volatility) is positive for the stock performance.
10 days
73.0%1 month
66.5%3 months
44.6%6 months
39.8%59.92
-
5.93
0.12
0.09
44.84
8.02
-
1.13B
26.44B
283.74M
-
9.84
213.00
33.60
9.92
-
-
Short-term: Bearish (SMA10D < SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bearish (SMA6M < SMA12M)
Range10D
70.95
Range1M
137.40
Range3M
325.00
Rel. volume
0.63
Price X volume
40.87M
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
|---|---|---|---|---|---|---|---|
| Gufic Biosciences Limited | GUFICBIO | Drug Manufacturers-Specialty & Generic | 288.7 | 28.96B | 5.44% | 50.00 | 62.51% |
| ZOTA | ZOTA | Biotechnology | 1116.2 | 28.94B | 4.83% | n/a | 105.90% |
| Bliss Gvs Pharma Limited | BLISSGVS | Drug Manufacturers-Specialty & Generic | 229.4 | 24.16B | 6.41% | 17.04 | 10.32% |
| Dishman Carbogen Amcis Limited | DCAL | Biotechnology | 146.14 | 22.91B | 12.44% | n/a | 41.09% |
| Unichem Laboratories Limited | UNICHEMLAB | Drug Manufacturers-Specialty & Generic | 298.2 | 21.07B | 1.62% | n/a | 10.48% |
| Morepen Laboratories Limited | MOREPENLAB | Drug Manufacturers-Specialty & Generic | 37.2 | 20.55B | 10.45% | 37.53 | 3.42% |
| Panacea Biotec Limited | PANACEABIO | Biotechnology | 325.3 | 20.30B | 9.88% | n/a | 2.49% |
| SOLARA | SOLARA | Drug Manufacturers-Specialty & Generic | 459.1 | 19.89B | 7.88% | n/a | 107.90% |
| Hikal Limited | HIKAL | Drug Manufacturers-Specialty & Generic | 159.96 | 19.72B | 8.76% | 69.03 | 68.84% |
| Alembic Limited | ALEMBICLTD | Drug Manufacturers-Specialty & Generic | 76.49 | 19.71B | 7.88% | 12.29 | 0.42% |
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
|---|---|---|---|---|---|---|---|
| Vertoz Advertising Limited | VERTOZ | Advertising Agencies | 31.14 | 27.32B | 10.46% | 48.67 | 10.74% |
| "SAI SILKS (KALAMANDIR) LIMITED " | KALAMANDIR | Apparel Retail | 101.34 | 14.93B | 12.25% | 28.83 | 43.67% |
| Signpost India Limited | SIGNPOST | Advertising Agencies | 231.11 | 13.55B | 4.36% | 30.54 | 80.30% |
| V2 Retail Limited | V2RETAIL | Apparel Retail | 189.42 | 6.76B | 0.17% | 120.49 | 191.28% |
| Bhagyanagar India Ltd | BHAGYANGR | Copper | 151.06 | 4.88B | 9.69% | 36.36 | 52.08% |
| Madhav Copper Limited | MCL | Copper | 57.49 | 1.59B | 4.99% | 82.22 | 32.14% |
| Cubex Tubings Limited | CUBEXTUB | Copper | 83.8 | 1.22B | 13.34% | 35.85 | 21.78% |
| Touchwood Entertainment Limited | TOUCHWOOD | Advertising Agencies | 65.89 | 734.59M | 4.50% | 50.06 | 4.88% |
| Sagardeep Alloys Limited | SAGARDEEP | Copper | 22.89 | 397.37M | 3.95% | 58.62 | 43.14% |
| Heads UP Ventures Limited | HEADSUP | Apparel Retail | 6.92 | 151.62M | 14.38% | n/a | 0.00% |
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | 44.84 | 24.85 | Expensive |
| Ent. to Revenue | 8.02 | 11.40 | Cheaper |
| PE Ratio | 59.92 | 51.36 | Par |
| Price to Book | 5.93 | 6.83 | Par |
| Dividend Yield | - | 0.52 | - |
| Std. Deviation (3M) | 44.56 | 42.17 | Par |
| Debt to Equity | 0.12 | 0.35 | Cheaper |
| Debt to Assets | 0.09 | 0.17 | Cheaper |
| Market Cap | 26.44B | 290.82B | Emerging |